DXB 1.28% 38.5¢ dimerix limited

Phase 3 clinical study in FSGS in the first half of 2021, page-4

  1. 4,093 Posts.
    lightbulb Created with Sketch. 269
    hang on I just read this properly. This is single handedly the worst post I've ever seen. you're telling me that this drug would get sales of 20 billion a year yet the price will only 10 bag if successful. if this brings in that amount, which it won't, the market cap would be up around the 100 billion mark or actually probably more..... a little more than 10 bag


    This post should be moderated as flagged as complete waffle (i wish there was a complete waffle button to report)

    I seriously worry about people investing these days, you are al going to go broke if this is what you think
    Last edited by Sparkiesteve: 20/10/20
 
watchlist Created with Sketch. Add DXB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.